Insulet (PODD) Other Operating Expenses (2010 - 2019)

Insulet has reported Other Operating Expenses for 10 years, with the latest figure at -$135.0 million in Q4 2019.

• For the quarter ending Q4 2019, Other Operating Expenses fell 27.83% year-over-year to -$135.0 million; the trailing twelve-month figure through Sep 2020 stood at -$135.0 million (down 559.26% YoY), and the FY2017 full-year result was $124.2 million, up 31.45% from the prior year.
• Other Operating Expenses for Q4 2019 stood at -$135.0 million, down from $47.2 million in the prior quarter.
• The five-year high for Other Operating Expenses was $47.2 million in Q3 2019, with the low at -$135.0 million in Q4 2019.
• Historically, Other Operating Expenses has averaged $14.9 million across 5 years, with a median of $26.7 million in 2016.
• Annual changes were most pronounced in 2015 — Other Operating Expenses soared 226.11% — and 2018, when it slumped 378.48%.
• Insulet's Other Operating Expenses stood at $23.4 million in 2015, then increased by 8.48% to $25.4 million in 2016, then surged by 49.47% to $37.9 million in 2017, then sank by 378.48% to -$105.6 million in 2018, then retreated by 27.83% to -$135.0 million in 2019.
• The last three Other Operating Expenses figures came in at -$135.0 million (Q4 2019), $47.2 million (Q3 2019), and $46.7 million (Q2 2019), per Business Quant data.